KLP Kapitalforvaltning’s Charles River Laboratories CRL Stock Holding History

KLP Kapitalforvaltning’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.54M	Sell	11,200 -1,400	-11%	-$249K	0.01%	666
2026 Q1	$2.17M	Sell	12,600 -200	-2%	-$37.1K	0.01%	683
2025 Q4	$2.55M	Sell	12,800 -100	-0.8%	-$18.1K	0.01%	622
2025 Q3	$2.02M	Buy	12,900 +2,800	+28%	+$445K	0.01%	701
2025 Q2	$1.53M	Buy	10,100 +200	+2%	+$26.7K	0.01%	771
2025 Q1	$1.49M	Sell	9,900 -9,600	-49%	-$1.61M	0.01%	753
2024 Q4	$3.6M	Buy	+19,500	New	+$3.76M	0.02%	536

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

KLP Kapitalforvaltning's CRL Position: Q2 2026 in Review

KLP Kapitalforvaltning reduced its Charles River Laboratories (CRL) stake by 11% in Q2 2026, selling an estimated $249K and leaving 11,200 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #666.

KLP Kapitalforvaltning first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.6M in Q4 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

KLP Kapitalforvaltning held 11,200 shares of Charles River Laboratories worth $2.54M as of Q2 2026.
KLP Kapitalforvaltning sold 1,400 Charles River Laboratories shares in Q2 2026, an estimated $249K.
Charles River Laboratories made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #666 holding.
KLP Kapitalforvaltning first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
KLP Kapitalforvaltning's Charles River Laboratories position peaked at $3.6M in Q4 2024.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.